As of 3:34pm ET
| -0.51 / -1.08%|
The 19 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 44.06, with a high estimate of 54.54 and a low estimate of 33.52. The median estimate represents a -5.67% decrease from the last price of 46.71.
The current consensus among 19 polled investment analysts is to Buy stock in Novozymes A/S. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.